Eleven Biotherapeutics (EBIO) Reports Q1 Loss of $0.33/Share

August 12, 2016 8:50 AM EDT
Get Alerts EBIO Hot Sheet
Trade EBIO Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Eleven Biotherapeutics (NASDAQ: EBIO) reported Q1 EPS of ($0.33), versus ($0.36) reported last year. Revenue for the quarter came in at $277 thousand, versus $114 thousand reported last year.

For earnings history and earnings-related data on Eleven Biotherapeutics (EBIO) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment